Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that ...
Shares of PayPay were indicated to open 37.5% above their offer price in their Nasdaq debut on Thursday, giving the SoftBank-backed Japanese payments ‌app a potential valuation of $14.71 billion.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results